BUDZ · XBRL financial data
Weed financial statements, every fiscal year
The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (BUDZ's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Revenue | 0 | — | 0 | 0 | 0 | 0 |
| Cost of revenue | — | — | 0 | 0 | 0 | 0 |
| Gross profit | — | — | 0 | 0 | 0 | 0 |
| General and administrative | 314 | 798 | 567 | 395 | 351 | 1,128 |
| Total operating expenses | 4,076 | 2,801 | 1,505 | 771 | 530 | 1,328 |
| Operating income (loss) | (4,076) | (2,801) | (1,505) | (771) | (530) | (1,328) |
| Interest expense | 41 | 39 | 117 | 45 | 5 | — |
| Other income (expense) | 11 | (40) | (23) | 740 | 35 | (44) |
| Income tax expense (benefit) | — | — | 0 | 1 | 0 | 0 |
| Net income (loss) | (4,065) | (2,842) | (1,528) | (32) | (511) | (1,372) |
| Earnings per share, basic USD per share | — | (0.02) | (0.01) | (0.00) | (0.00) | — |
| Earnings per share, diluted USD per share | — | — | — | (0.00) | (0.00) | (0.01) |
| Weighted average shares, basic thousands of shares | — | 116,733 | 122,077 | 123,709 | 124,133 | — |
| Weighted average shares, diluted thousands of shares | — | — | — | 123,709 | 124,133 | 135,920 |
Balance sheet
CSVFiscal years (BUDZ's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 13 | 20 | 316 | 290 | 159 | 33 |
| Accounts receivable | 1 | 1 | — | — | — | — |
| Total current assets | 255 | 42 | 342 | 320 | 190 | 48 |
| Property and equipment, net | 1,521 | 1,877 | 1,209 | 516 | 496 | 476 |
| Right-of-use asset | — | — | 44 | 32 | 19 | 5 |
| Goodwill | — | 0 | 0 | 0 | — | — |
| Total assets | 1,819 | 1,959 | 1,634 | 904 | 738 | 560 |
| Accounts payable | 242 | 246 | 190 | 184 | 168 | 180 |
| Accrued liabilities | 272 | 17 | 42 | 65 | 85 | 111 |
| Total current liabilities | 937 | 1,342 | 1,464 | 649 | 959 | 1,248 |
| Total liabilities | 937 | 1,342 | 1,464 | 649 | 959 | 1,248 |
| Accumulated deficit | (79,991) | (82,833) | (84,361) | (84,393) | (84,903) | (86,275) |
| Total stockholders' equity | 882 | 618 | 170 | 255 | (221) | (688) |
| Total liabilities and equity | 1,819 | 1,959 | 1,634 | 904 | 738 | 560 |
| Common shares outstanding (cover page) thousands of shares | 114,263 | 120,833 | 123,483 | 123,483 | 123,483 | 148,313 |
Cash flows
CSVFiscal years (BUDZ's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Net income (loss) | (4,065) | (2,842) | (1,528) | (32) | (511) | (1,372) |
| Stock-based compensation | 2,016 | 2,003 | — | — | 20 | 800 |
| Depreciation and amortization | — | — | — | 52 | 23 | 22 |
| Net cash from operating activities | (431) | (569) | (813) | (1,074) | (416) | (195) |
| Purchases of property and equipment | 0 | 271 | 0 | 10 | — | — |
| Net cash from investing activities | 164 | (271) | 1,257 | 1,631 | — | — |
| Proceeds from issuing common stock | — | — | 40 | 0 | — | — |
| Proceeds from issuing equity | 295 | 560 | 40 | — | — | — |
| Net cash from financing activities | 277 | 849 | (149) | (588) | 285 | 70 |
| Net change in cash | — | 8 | 295 | (31) | (130) | — |
Compare with peers
SIC 8731 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 8731 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Weed | 1.1 | 0 | (19)* | 148.3M | 0.1 quarters | 10-QJun 30, 2026 |
| Foxo Technologies | 58 | 4,715 | 299* | 1.7M | — | 10-QJun 30, 2026 |
| iSpecimen | 4,414 | 152 | (690)* | 2.5M | 6.4 quarters | 10-QJun 30, 2026 |
| Cannabis Bioscience International Holdings | 0.1 | 11 | (15)* | 11.6B | 0.0 quarters | 10-QFeb 28, 2026 |
| Hypha Labs | 5.1 | not reported | (52)* | 163.9M | 0.1 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.